Page last updated: 2024-09-03

2'-cyano-2'-deoxyarabinofuranosylcytosine and 2'-deoxycytidine 5'-triphosphate

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with 2'-deoxycytidine 5'-triphosphate in 1 studies

Compound Research Comparison

Studies
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Trials
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Recent Studies (post-2010)
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Studies
(2'-deoxycytidine 5'-triphosphate)
Trials
(2'-deoxycytidine 5'-triphosphate)
Recent Studies (post-2010) (2'-deoxycytidine 5'-triphosphate)
3106435367

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, A; Huang, P; Matsuda, A; Plunkett, W1

Other Studies

1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and 2'-deoxycytidine 5'-triphosphate

ArticleYear
Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC).
    Biochemical pharmacology, 2001, Jun-15, Volume: 61, Issue:12

    Topics: Antineoplastic Agents; Cell Division; Cytarabine; Deoxycytosine Nucleotides; Deoxyribonucleotides; DNA; Humans; RNA; Tumor Cells, Cultured

2001